biote Stock (NASDAQ:BTMD)
Previous Close
$2.46
52W Range
$1.27 - $4.75
50D Avg
$2.08
200D Avg
$2.40
Market Cap
$99.24M
Avg Vol (3M)
$255.14K
Beta
1.66
Div Yield
-
BTMD Company Profile
Biote Corp. is dedicated to supporting and developing medical practices that focus on hormone optimization. The company provides a comprehensive system for its Biote-certified healthcare professionals, enabling them to correct imbalances in patients' hormone, vitamin, and mineral levels. This includes authorizing the prescription of bioidentical hormone treatments and suggesting suitable dietary supplements. Furthermore, Biote offers its own line of branded nutritional supplements and supplies sterile kits for inserting hormone pellets for both male and female individuals. Founded in 2011, Biote Corp. is based in Irvine, Texas.
BTMD Performance
Revenue Breakdown
Revenue Breakdown by Product/Service
| Product/Service | Dec 25 | Dec 24 | Dec 23 |
|---|---|---|---|
| Dietary Supplements | $42.88M | $36.02M | $38.09M |
| Other Service Revenue | $2.86M | $2.27M | $697.00K |
| Product Revenue | $186.92M | $192.24M | $182.57M |
| Service Revenue | $5.29M | $4.95M | $2.79M |
| Training Service Revenue | $1.08M | $1.46M | $1.17M |
Fiscal year ends in Dec 25 | Currency in USD